发明名称 PYRROLIDINE DERIVATIVE OR SALT THEREOF
摘要 [Problem] To provide a compound which may be used in treating diseases in which a calcium sensing receptor (CaSR) is concerned, particularly hyperparathyroidism. [Means for Resolution] It was found that novel pyrrolidine derivatives which are characterized by the possession of aminomethyl group substituted with arylalkyl group or the like, or salts thereof, have excellent CaSR agonistic regulatory activity and also have excellent selectivity with CYP2D6 inhibitory activity having a possibility of causing drug interaction. Based on the above, these novel pyrrolidine derivatives are useful as therapeutic agents for treating diseases in which CaSR is concerned (hyperparathyroidism, renal osteodystrophy, hypercalcemia and the like).
申请公布号 CA2608957(C) 申请公布日期 2013.12.10
申请号 CA20062608957 申请日期 2006.05.18
申请人 ASTELLAS PHARMA INC. 发明人 HACHIYA, SHUNICHIRO;OKU, MAKOTO;MUKAI, HANA;SHIN, TAKASHI;MATSUURA, KEISUKE;SEO, RYUSHI;KAMIKUBO, TAKASHI;TERADA, YOH;SANAGI, MASANAO;YOSHIHARA, KOUSEI;TAKAHASHI, TAISUKE
分类号 C07D207/09;A61K31/40;A61K31/402;A61K31/4025;A61K31/403;A61K31/404;A61K31/407;A61K31/41;A61K31/427;A61K31/437;A61K31/4439;A61K31/454;A61K31/496;A61K31/5377;A61K31/541;A61P3/14;A61P5/20;A61P19/08;A61P43/00;C07D207/16;C07D207/34;C07D207/48;C07D401/04;C07D401/06;C07D401/12;C07D403/06;C07D403/10;C07D405/04;C07D405/06;C07D405/12;C07D409/04;C07D409/06;C07D409/12;C07D409/14;C07D413/10;C07D417/06 主分类号 C07D207/09
代理机构 代理人
主权项
地址